[go: up one dir, main page]

CN110590685A - Preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole - Google Patents

Preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole Download PDF

Info

Publication number
CN110590685A
CN110590685A CN201910886781.1A CN201910886781A CN110590685A CN 110590685 A CN110590685 A CN 110590685A CN 201910886781 A CN201910886781 A CN 201910886781A CN 110590685 A CN110590685 A CN 110590685A
Authority
CN
China
Prior art keywords
triazole
trisubstituted
thiocyanate
compound
thiocyanato
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201910886781.1A
Other languages
Chinese (zh)
Inventor
宋汪泽
李明
董锟
郑玉斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University of Technology
Original Assignee
Dalian University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University of Technology filed Critical Dalian University of Technology
Priority to CN201910886781.1A priority Critical patent/CN110590685A/en
Publication of CN110590685A publication Critical patent/CN110590685A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明属于有机合成技术领域,提供了一种新型5‑硫氰酸酯取代的1,4,5‑三取代的1,2,3‑三唑的制备方法及应用。本发明中5‑硫氰酸酯取代的1,4,5‑三取代的1,2,3‑三唑的制备方法以及5‑硫代‑1,4,5‑三取代的1,2,3‑三唑的制备方法反应条件温和,产物收率不低于62%。该制备方法的反应条件温和、绿色、反应效率高,更适合规模化生产要求,制备得到的5‑硫代‑1,4,5‑三取代的1,2,3‑三唑类化合物具有潜在的生理活性。The invention belongs to the technical field of organic synthesis, and provides a preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole. In the present invention, the preparation method of 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole and 5-thio-1,4,5-trisubstituted 1,2, The preparation method of 3-triazole has mild reaction conditions, and the product yield is not less than 62%. The preparation method has mild reaction conditions, greenness and high reaction efficiency, and is more suitable for large-scale production requirements, and the prepared 5-thio-1,4,5-trisubstituted 1,2,3-triazole compounds have potential physiological activity.

Description

一种新型5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑的制 备方法及应用Preparation of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole Preparation method and application

技术领域technical field

本发明属于有机合成技术领域,涉及一种新型5-硫代-1,4,5-三取代的1,2,3-三唑的制备方法,包括5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑的制备方法以及5-硫代-1,4,5-三取代的1,2,3-三唑的制备方法。The invention belongs to the technical field of organic synthesis, and relates to a preparation method of a novel 5-thio-1,4,5-trisubstituted 1,2,3-triazole, comprising 5-thiocyanate-substituted 1,4-triazole , The preparation method of 5-trisubstituted 1,2,3-triazole and the preparation method of 5-thio-1,4,5-trisubstituted 1,2,3-triazole.

背景技术Background technique

叠氮-炔烃环加成反应是制备1,2,3-三唑类化合物最重要的方法之一。近年来,已有一系列文献或专利报道了1,2,3-三唑类化合物的制备方法。但是,对于叠氮-硫氰酸酯基内炔烃参与的环加成反应,生成5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑的方法,尚未见文献报道。如何实现叠氮-硫氰酸酯基内炔烃参与的环加成反应并提高反应的区域选择性是我们关注的重点。5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑理论上可以通过与格式试剂或锂试剂反应,进一步转化为5-硫代-1,4,5-三取代的1,2,3-三唑。但是目前尚未见相关报道。虽然目前已有一些叠氮-硫代内炔环加成反应制备5-硫代-1,4,5-三取代的1,2,3-三唑的方法被报道出来(Angew.Chem.Int.Ed.2017,56,10766及Angew.Chem.Int.Ed.2014,53,1877),但是对于以硫氰酸酯基内炔烃为原料,通过“一锅法”制备5-硫代-1,4,5-三取代的1,2,3-三唑的技术还有待于进一步的拓展。5-硫代-1,4,5-三取代的1,2,3-三唑类化合物是具有潜在生物活性的重要化合物,因此研究其制备方法有重要的意义。The azide-alkyne cycloaddition reaction is one of the most important methods for the preparation of 1,2,3-triazoles. In recent years, a series of literatures or patents have reported the preparation methods of 1,2,3-triazole compounds. However, the method of producing 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole in a cycloaddition reaction involving an alkyne in an azide-thiocyanate group, Not yet reported in the literature. How to realize the cycloaddition reaction involving alkynes in the azide-thiocyanate group and improve the regioselectivity of the reaction is the focus of our attention. 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazoles can theoretically be further converted to 5-thio-1,4,5 by reacting with Grignard or lithium reagents - Trisubstituted 1,2,3-triazoles. But so far there are no relevant reports. Although some azido-thioendyne cycloadditions have been reported to prepare 5-thio-1,4,5-trisubstituted 1,2,3-triazoles (Angew.Chem.Int .Ed.2017,56,10766 and Angew.Chem.Int.Ed.2014,53,1877), but for the preparation of 5-thio- The technology of 1,4,5-trisubstituted 1,2,3-triazole still needs to be further developed. 5-thio-1,4,5-trisubstituted 1,2,3-triazoles are important compounds with potential biological activity, so it is of great significance to study their preparation methods.

本发明采用了各种硫氰酸酯基内炔烃和有机叠氮化合物为原料,使用2.5mol%[Cp*Ru(COD)Cl]作为催化剂,在室温条件下,反应12-24小时,最终以66%~85%的收率得到5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑类化合物。接着采用了各种硫氰酸酯基内炔烃、有机叠氮化合物和格式试剂或锂试剂为原料,使用2.5mol%[Cp*Ru(COD)Cl]作为催化剂,通过三组份“一锅法”反应,在24-36小时,最终以62%~79%的收率得到5-硫代-1,4,5-三取代的1,2,3-三唑类化合物。The invention adopts various thiocyanate-based internal alkynes and organic azide compounds as raw materials, uses 2.5mol% [Cp*Ru(COD)Cl] as a catalyst, and reacts at room temperature for 12-24 hours. 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole compounds were obtained in a yield of 66% to 85%. Then, various thiocyanate-based alkynes, organic azides and Grignard reagents or lithium reagents were used as raw materials, and 2.5mol% [Cp*Ru(COD)Cl] was used as a catalyst. method" reaction, in 24-36 hours, 5-thio-1,4,5-trisubstituted 1,2,3-triazole compounds were finally obtained with a yield of 62% to 79%.

发明内容SUMMARY OF THE INVENTION

本发明要解决的技术问题是提供合成5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑的制备方法以及5-硫代-1,4,5-三取代的1,2,3-三唑的制备方法。The technical problem to be solved by the present invention is to provide a preparation method for synthesizing 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole and 5-thio-1,4,5- Preparation method of trisubstituted 1,2,3-triazoles.

本发明的技术方案:Technical scheme of the present invention:

一种新型5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑的制备方法,步骤如下:A preparation method of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole, the steps are as follows:

在有机溶剂中,在五甲基环戊二烯基1,5-环辛二烯基氯化钌([Cp*Ru(COD)Cl])催化剂作用下,催化硫氰酸酯基内炔烃类化合物与有机叠氮化合物的反应制备5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑,反应式如下:Catalysis of thiocyanate-based internal alkynes under the action of pentamethylcyclopentadienyl 1,5-cyclooctadienyl ruthenium chloride ([Cp*Ru(COD)Cl]) catalyst in organic solvent 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazoles are prepared by the reaction of these compounds with organic azides, and the reaction formula is as follows:

其中,R1和R2为烷基或芳基,R1和R2相同或不同;wherein, R 1 and R 2 are alkyl or aryl groups, and R 1 and R 2 are the same or different;

I为硫氰酸酯基内炔烃类化合物;I is a thiocyanate group internal alkyne compound;

所述的硫氰酸酯基内炔烃类化合物与有机叠氮化合物的摩尔比为1:1.5-1:3,硫氰酸酯基内炔烃类化合物在体系中的浓度0.01-0.1mmol/ml;The molar ratio of the alkyne compound in the thiocyanate group to the organic azide compound is 1:1.5-1:3, and the concentration of the alkyne compound in the thiocyanate group in the system is 0.01-0.1mmol/ ml;

所述的[Cp*Ru(COD)Cl]的用量为硫氰酸酯基内炔烃类化合物的0.5~50mol%;The dosage of the [Cp*Ru(COD)Cl] is 0.5-50 mol% of the alkyne compound in the thiocyanate group;

反应温度为室温~80℃,反应时间为12h~24h,制备得到收率不低于66%的5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑;The reaction temperature is room temperature to 80°C, and the reaction time is 12h to 24h, and the 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole is prepared in a yield of not less than 66%. ;

所述的有机溶剂为苯、甲苯、乙醚、甲基叔丁基醚、二氯甲烷、四氢呋喃、三氟甲苯、环己烷、石油醚中的一种或两种以上混合,优选溶剂为四氢呋喃、二氯甲烷或氯仿。Described organic solvent is benzene, toluene, ether, methyl tertiary butyl ether, dichloromethane, tetrahydrofuran, trifluorotoluene, cyclohexane, one or more mixing of petroleum ether, preferably solvent is tetrahydrofuran, Dichloromethane or chloroform.

一种新型5-硫代-1,4,5-三取代的1,2,3-三唑的制备方法,步骤如下:A preparation method of a novel 5-thio-1,4,5-trisubstituted 1,2,3-triazole, the steps are as follows:

在有机溶剂中,在五甲基环戊二烯基1,5-环辛二烯基氯化钌([Cp*Ru(COD)Cl])催化剂作用下,硫氰酸酯基内炔烃类化合物与有机叠氮化合物的反应原位生成5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑,该5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑继续与格式试剂或锂试剂发生反应生成新型5-硫代-1,4,5-三取代的1,2,3-三唑,反应式如下:In organic solvents, under the action of pentamethylcyclopentadienyl 1,5-cyclooctadienyl ruthenium chloride ([Cp*Ru(COD)Cl]) catalyst, thiocyanate-based internal alkynes The reaction of the compound with an organic azide generates a 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole in situ, the 5-thiocyanate-substituted 1,4, The 5-trisubstituted 1,2,3-triazole continues to react with Grignard reagent or lithium reagent to form a new 5-thio-1,4,5-trisubstituted 1,2,3-triazole. The reaction formula is as follows :

其中,R1,R2和R3为烷基或芳基,R4为烷基;Wherein, R 1 , R 2 and R 3 are alkyl or aryl, and R 4 is alkyl;

I为硫氰酸酯基内炔烃类化合物;I is a thiocyanate group internal alkyne compound;

IV为格式试剂;IV is format reagent;

VI为锂试剂;VI is lithium reagent;

所述的硫氰酸酯基内炔烃类化合物、有机叠氮化合物与格式试剂或锂试剂的摩尔比为1:1.5:2-1:3:4,硫氰酸酯基内炔烃类化合物在体系中的浓度0.01-0.1mmol/ml;The molar ratio of the thiocyanate group internal alkyne compound, organic azide compound and Grignard reagent or lithium reagent is 1:1.5:2-1:3:4, and the thiocyanate group internal alkyne compound The concentration in the system is 0.01-0.1 mmol/ml;

所述的[Cp*Ru(COD)Cl]的用量为硫氰酸酯基内炔烃类化合物的0.5~50mol%;The dosage of the [Cp*Ru(COD)Cl] is 0.5-50 mol% of the alkyne compound in the thiocyanate group;

反应温度为0℃-室温,反应时间为24h~36h,制备得到收率不低于62%的5-硫代-1,4,5-三取代的1,2,3-三唑类化合物。The reaction temperature is 0°C to room temperature, and the reaction time is 24h-36h, and a 5-thio-1,4,5-trisubstituted 1,2,3-triazole compound with a yield of not less than 62% is prepared.

所述的有机溶剂为苯、甲苯、乙醚、甲基叔丁基醚、二氯甲烷、四氢呋喃、三氟甲苯、环己烷、石油醚中的一种或两种以上混合,优选溶剂为四氢呋喃、二氯甲烷或氯仿。Described organic solvent is benzene, toluene, ether, methyl tertiary butyl ether, dichloromethane, tetrahydrofuran, trifluorotoluene, cyclohexane, one or more mixing of petroleum ether, preferably solvent is tetrahydrofuran, Dichloromethane or chloroform.

所述的格式试剂是1.0mol/L苯基溴化镁的THF溶液、1.0mol/L甲基溴化镁的THF溶液、1.0mol/L异丙基溴化镁的THF溶液或1.0mol/L环丙基溴化镁的THF溶液。Described Grignard reagent is the THF solution of 1.0mol/L phenylmagnesium bromide, the THF solution of 1.0mol/L methylmagnesium bromide, the THF solution of 1.0mol/L isopropylmagnesium bromide or 1.0mol/L Cyclopropylmagnesium bromide in THF.

所述的锂试剂是2.5mol/L正丁基锂的正己烷溶液。The lithium reagent is a n-hexane solution of 2.5mol/L n-butyllithium.

本发明的有益效果:本发明中5-硫氰酸酯取代的1,4,5-三取代的1,2,3-三唑的制备方法以及5-硫代-1,4,5-三取代的1,2,3-三唑的制备方法反应条件温和,产物收率不低于62%。该制备方法的反应条件温和、绿色、反应效率高,更适合规模化生产要求,制备得到的5-硫代-1,4,5-三取代的1,2,3-三唑类化合物具有潜在的生理活性。Beneficial effects of the present invention: the preparation method of 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole and 5-thio-1,4,5-triazole in the present invention The preparation method of the substituted 1,2,3-triazole has mild reaction conditions, and the product yield is not less than 62%. The reaction conditions of the preparation method are mild, green, and the reaction efficiency is high, which is more suitable for large-scale production requirements, and the prepared 5-thio-1,4,5-trisubstituted 1,2,3-triazole compounds have potential physiological activity.

具体实施方式Detailed ways

以下结合技术方案,进一步说明本发明的具体实施方式。The specific embodiments of the present invention are further described below in conjunction with the technical solutions.

实施例1:5-硫氰酸酯基-(1-苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 1: Preparation of 5-thiocyanato-(1-benzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到白色固体产物48mg,产率82%。1-Phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, and benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD) were added Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature for 12h, spin-dried and separated by column chromatography to obtain 48mg of a white solid product with a yield of 82%.

Mp=88-90℃..1H NMR(400MHz,CDCl3,TMS):δ7.98-7.95(m,2H),7.55-7.48(m,3H),7.42-7.37(m,5H),5.80(s,2H).13C NMR(100MHz,CDCl3):δ152.0,133.4,129.7,129.3,129.1,129.0,128.5,127.9,127.7,112.3,106.2,53.6.HRMS(ESI-TOF)m/z calcd forC16H12N4S(M+Na)+315.0674,found 315.0679.Mp=88-90°C.. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.98-7.95 (m, 2H), 7.55-7.48 (m, 3H), 7.42-7.37 (m, 5H), 5.80 (s, 2H). 13 C NMR (100 MHz, CDCl 3 ): δ 152.0, 133.4, 129.7, 129.3, 129.1, 129.0, 128.5, 127.9, 127.7, 112.3, 106.2, 53.6. HRMS(ESI-TOF) m/z calcd forC 16 H 12 N 4 S(M+Na) + 315.0674, found 315.0679.

实施例2:5-硫氰酸酯基-(1-苄基)-4-对甲氧基苯基-1H-1,2,3-三氮唑的制备Example 2: Preparation of 5-thiocyanato-(1-benzyl)-4-p-methoxyphenyl-1H-1,2,3-triazole

在空气下,将1-对甲氧基苯乙炔基硫氰酸酯(0.2mmol,37.8mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到白色固体产物50mg,产率78%。Under air, 1-p-methoxyphenethynyl thiocyanate (0.2 mmol, 37.8 mg) was dissolved in tetrahydrofuran (2 mL), benzyl azide (0.3 mmol, 40.2 mg) and [Cp* Ru(COD)Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature, reacted for 12h, spin-dried and separated by column chromatography to obtain 50mg of white solid product with a yield of 78%.

Mp=132-134℃.1H NMR(400MHz,CDCl3,TMS):δ7.93(d,J=8.0Hz,2H),7.40-7.37(m,3H),7.05(d,J=8.0Hz,2H),5.79(s,2H),3.89(s,3H).13C NMR(100MHz,CDCl3):δ160.8,151.9,133.5,129.3,129.1,127.9,121.0,114.4,111.3,106.4,55.4,53.5.HRMS(ESI-TOF)m/z calcd for C17H14N4OS(M+Na)+345.0781,found 345.0784.Mp=132-134°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.93 (d, J=8.0 Hz, 2H), 7.40-7.37 (m, 3H), 7.05 (d, J=8.0 Hz) , 2H), 5.79(s, 2H), 3.89(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δ160.8, 151.9, 133.5, 129.3, 129.1, 127.9, 121.0, 114.4, 111.3, 106.4, 55.4, 53.5. HRMS(ESI-TOF) m/z calcd for C 17 H 14 N 4 OS(M+Na) + 345.0781, found 345.0784.

实施例3:5-硫氰酸酯基-(1-苄基)-4-对甲基苯基-1H-1,2,3-三氮唑的制备在空气下,将1-对甲基苯乙炔基硫氰酸酯(0.2mmol,34.6mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到白色固体产物47mg,产率77%。Example 3: Preparation of 5-thiocyanato-(1-benzyl)-4-p-methylphenyl-1H-1,2,3-triazole Phenylethynyl thiocyanate (0.2 mmol, 34.6 mg) was dissolved in tetrahydrofuran (2 mL), then benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD)Cl] (0.005 mmol, 1.9 mg), the reaction mixture was stirred at room temperature, reacted for 12 h, and was separated by column chromatography after spin-drying to obtain 47 mg of a white solid product with a yield of 77%.

Mp=57-59℃.1H NMR(400MHz,CDCl3,TMS):δ7.83(d,J=8.0Hz,2H),7.40-7.32(m,5H),7.31(d,J=8.0Hz,2H),5.78(s,2H),2.41(s,3H).13C NMR(100MHz,CDCl3):δ154.6,147.3,134.2,132.8,130.3,129.2,129.1,129.1,128.9,128.5,127.9,53.1,21.9.HRMS(ESI-TOF)m/z calcd for C17H14N4S(M+Na)+329.0831,found 329.0835.Mp=57-59°C. 1 H NMR (400MHz, CDCl 3 , TMS): δ 7.83 (d, J=8.0Hz, 2H), 7.40-7.32 (m, 5H), 7.31 (d, J=8.0Hz) , 2H), 5.78(s, 2H), 2.41(s, 3H). 13 C NMR (100MHz, CDCl 3 ): δ154.6, 147.3, 134.2, 132.8, 130.3, 129.2, 129.1, 129.1, 128.9, 128.5, 127.9, 53.1, 21.9. HRMS(ESI-TOF) m/z calcd for C 17 H 14 N 4 S(M+Na) + 329.0831, found 329.0835.

实施例4:5-硫氰酸酯基-(1-苄基)-4-对溴苯基-1H-1,2,3-三氮唑的制备Example 4: Preparation of 5-thiocyanato-(1-benzyl)-4-p-bromophenyl-1H-1,2,3-triazole

在空气下,将1-对溴苯乙炔基硫氰酸酯(0.2mmol,47.2mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到白色固体产物52mg,产率71%。Under air, 1-p-bromophenylethynyl thiocyanate (0.2 mmol, 47.2 mg) was dissolved in tetrahydrofuran (2 mL), and benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru ( COD)Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature, reacted for 12h, spin-dried and separated by column chromatography to obtain 52mg of white solid product with a yield of 71%.

Mp=156-158℃.1H NMR(400MHz,CDCl3,TMS):δ7.83(d,J=8.0Hz,2H),7.64(d,J=8.0Hz,2H),7.41-7.35(m,5H),5.78(s,2H).13C NMR(100MHz,CDCl3):δ150.9,133.2,132.2,129.3,129.2,129.1,128.0,127.5,124.3,112.5,105.9,53.6.HRMS(ESI-TOF)m/z calcdfor C16H11BrN4S(M+Na)+392.9780,found 392.9781.Mp=156-158°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.83 (d, J=8.0 Hz, 2H), 7.64 (d, J=8.0 Hz, 2H), 7.41-7.35 (m , 5H), 5.78(s, 2H). 13 C NMR (100MHz, CDCl 3 ): δ150.9, 133.2, 132.2, 129.3, 129.2, 129.1, 128.0, 127.5, 124.3, 112.5, 105.9, 53.6.HRMS (ESI-TOF )m/z calcd for C 16 H 11 BrN 4 S(M+Na) + 392.9780, found 392.9781.

实施例5:5-硫氰酸酯基-(1-苄基)-4-间甲基苯基-1H-1,2,3-三氮唑的制备在空气下,将1-间甲基苯乙炔基硫氰酸酯(0.2mmol,34.6mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到白色固体产物52mg,产率85%。Example 5: Preparation of 5-thiocyanato-(1-benzyl)-4-m-methylphenyl-1H-1,2,3-triazole Phenylethynyl thiocyanate (0.2 mmol, 34.6 mg) was dissolved in tetrahydrofuran (2 mL), then benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD)Cl] (0.005 mmol, 1.9 mg), the reaction mixture was stirred at room temperature, reacted for 12 h, and was separated by column chromatography after spin-drying to obtain 52 mg of a white solid product with a yield of 85%.

Mp=95-97℃.1H NMR(400MHz,CDCl3,TMS):δ7.76(s,1H),7.72(d,J=8.0Hz,1H),7.41-7.34(m,6H),7.28-7.26(m,1H),5.78(s,2H),2.43(s,3H).13C NMR(100MHz,CDCl3):δ152.1,138.8,133.5,130.5,129.3,129.1,128.9,128.4,127.9,127.7,124.8,112.4,106.4,53.5,21.5.HRMS(ESI-TOF)m/z calcd for C17H14N4S(M+Na)+329.0832,found329.0836.Mp=95-97°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.76 (s, 1H), 7.72 (d, J=8.0 Hz, 1H), 7.41-7.34 (m, 6H), 7.28 -7.26(m, 1H), 5.78(s, 2H), 2.43(s, 3H). 13 C NMR (100 MHz, CDCl 3 ): δ152.1, 138.8, 133.5, 130.5, 129.3, 129.1, 128.9, 128.4, 127.9, 127.7,124.8,112.4,106.4,53.5,21.5.HRMS(ESI-TOF)m/z calcd for C 17 H 14 N 4 S(M+Na) + 329.0832,found329.0836.

实施例6:5-硫氰酸酯基-(1-苄基)-4-邻甲氧基苯基-1H-1,2,3-三氮唑的制备Example 6: Preparation of 5-thiocyanato-(1-benzyl)-4-o-methoxyphenyl-1H-1,2,3-triazole

在空气下,将1-邻甲氧基苯乙炔基硫氰酸酯(0.2mmol,37.8mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到白色固体产物49mg,产率76%。Under air, 1-o-methoxyphenylethynyl thiocyanate (0.2 mmol, 37.8 mg) was dissolved in tetrahydrofuran (2 mL), benzyl azide (0.3 mmol, 40.2 mg) and [Cp* Ru(COD)Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature, reacted for 12h, spin-dried and separated by column chromatography to obtain 49mg of white solid product with a yield of 76%.

Mp=103-105℃.1H NMR(400MHz,CDCl3,TMS):δ7.64(d,J=8.0Hz,1H),7.50(t,J=8.0Hz,1H),7.47-7.40(m,5H),7.12(t,J=8.0Hz,1H),7.03(d,J=8.0Hz,1H),5.82(s,2H),3.85(s,3H).13C NMR(100MHz,CDCl3):δ156.3,149.7,133.5,131.4,131.2,129.2,129.0,128.1,121.1,117.6,115.6,111.1,107.3,55.5,53.6.HRMS(ESI-TOF)m/z calcd forC17H14N4OS(M+Na)+345.0781,found 345.0784.Mp=103-105°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.64 (d, J=8.0 Hz, 1H), 7.50 (t, J=8.0 Hz, 1H), 7.47-7.40 (m , 5H), 7.12(t, J=8.0Hz, 1H), 7.03(d, J=8.0Hz, 1H), 5.82(s, 2H), 3.85(s, 3H). 13 C NMR(100MHz, CDCl 3 ):δ156.3,149.7,133.5,131.4,131.2,129.2,129.0,128.1,121.1,117.6,115.6,111.1,107.3,55.5,53.6.HRMS(ESI-TOF)m/z calcd forC 17 H 14 N 4 OS( M+Na) + 345.0781, found 345.0784.

实施例7:5-硫氰酸酯基-(1-对甲氧基苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 7: Preparation of 5-thiocyanato-(1-p-methoxybenzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入对甲氧基苄基叠氮(0.3mmol,48.9mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到黄色固体产物52mg,产率80%。1-Phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, and p-methoxybenzyl azide (0.3 mmol, 48.9 mg) and [Cp* Ru(COD)Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature, reacted for 12h, spin-dried and separated by column chromatography to obtain 52mg of yellow solid product with a yield of 80%.

Mp=75-77℃.1H NMR(400MHz,CDCl3,TMS):δ7.96(d,J=8.0Hz,2H),7.54-7.48(m,3H),7.36(d,J=12.0Hz,2H),6.93(d,J=8.0Hz,2H),5.74(s,2H),3.81(s,3H).13C NMR(100MHz,CDCl3):δ160.2,151.8,129.7,129.6,129.0,128.6,127.7,125.4,114.6,112.2,106.5,55.4,53.1.HRMS(ESI-TOF)m/z calcd for C17H14N4OS(M+Na)+345.0781,found345.0783.Mp=75-77°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.96 (d, J=8.0 Hz, 2H), 7.54-7.48 (m, 3H), 7.36 (d, J=12.0 Hz) , 2H), 6.93(d, J=8.0Hz, 2H), 5.74(s, 2H), 3.81(s, 3H). 13 C NMR (100 MHz, CDCl 3 ): δ 160.2, 151.8, 129.7, 129.6, 129.0, 128.6,127.7,125.4,114.6,112.2,106.5,55.4,53.1.HRMS(ESI-TOF)m/z calcd for C 17 H 14 N 4 OS(M+Na) + 345.0781,found345.0783.

实施例8:5-硫氰酸酯基-(1-对氯苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 8: Preparation of 5-thiocyanato-(1-p-chlorobenzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入对氯苄基叠氮(0.3mmol,50.1mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到黄色固体产物46mg,产率71%。Under air, 1-phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL), and p-chlorobenzyl azide (0.3 mmol, 50.1 mg) and [Cp*Ru ( COD)Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature, reacted for 12h, spin-dried and separated by column chromatography to obtain 46mg of a yellow solid product with a yield of 71%.

Mp=107-109℃.1H NMR(400MHz,CDCl3,TMS):δ7.96(d,J=8.0Hz,2H),7.54-7.50(m,3H),7.41(d,J=8.0Hz,2H),7.34(d,J=8.0Hz,2H),5.78(s,2H).13C NMR(100MHz,CDCl3):δ152.0,135.3,131.8,129.8,129.5,129.4,129.0,128.4,127.7,112.4,106.1,52.7.HRMS(ESI-TOF)m/z calcd for C16H11ClN4S(M+Na)+349.0285,found 349.0285.Mp=107-109°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.96 (d, J=8.0 Hz, 2H), 7.54-7.50 (m, 3H), 7.41 (d, J=8.0 Hz) , 2H), 7.34 (d, J=8.0Hz, 2H), 5.78 (s, 2H). 13 C NMR (100 MHz, CDCl 3 ): δ 152.0, 135.3, 131.8, 129.8, 129.5, 129.4, 129.0, 128.4, 127.7 ,112.4,106.1,52.7.HRMS(ESI-TOF)m/z calcd for C 16 H 11 ClN 4 S(M+Na) + 349.0285,found 349.0285.

实施例9:5-硫氰酸酯基-[1-(2,3,4,5-四氢-1’-苯基)]-4-苯基-1H-1,2,3-三氮唑的制备Example 9: 5-thiocyanato-[1-(2,3,4,5-tetrahydro-1'-phenyl)]-4-phenyl-1H-1,2,3-triazo Preparation of azoles

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入二级叠氮(0.3mmol,60.0mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h,旋干后柱层析分离得到棕色液体产物47mg,产率66%。1-Phenylethynylthiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, followed by the addition of secondary azide (0.3 mmol, 60.0 mg) and [Cp*Ru(COD) Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature, reacted for 12h, spin-dried and separated by column chromatography to obtain 47mg of brown liquid product with a yield of 66%.

1H NMR(400MHz,CDCl3,TMS):δ7.89(d,J=4.0Hz,2H),7.51-7.45(m,3H),7.25-7.18(m,5H),6.47(t,J=4.0Hz,1H),6.07(t,J=4.0Hz,1H),2.60-2.54(m,1H),2.43-2.29(m,3H),2.10-2.05(m,1H),1.91-1.85(m,1H).13C NMR(100MHz,CDCl3):δ151.2,138.9,133.7,133.0,129.5,128.9,128.7,128.6,127.8,127.6,126.0,111.7,107.1,57.1,30.6,25.5,18.1.HRMS(ESI-TOF)m/z calcd for C21H18N4S(M+Na)+381.1144,found 381.1145. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 7.89 (d, J=4.0 Hz, 2H), 7.51-7.45 (m, 3H), 7.25-7.18 (m, 5H), 6.47 (t, J= 4.0Hz, 1H), 6.07(t, J=4.0Hz, 1H), 2.60-2.54(m, 1H), 2.43-2.29(m, 3H), 2.10-2.05(m, 1H), 1.91-1.85(m , 1H). 13 C NMR (100MHz, CDCl 3 ): δ151.2, 138.9, 133.7, 133.0, 129.5, 128.9, 128.7, 128.6, 127.8, 127.6, 126.0, 111.7, 107.1, 57.1, 30.6, 25.5, 18.1.HRMS ( ESI-TOF)m/z calcd for C 21 H 18 N 4 S(M+Na) + 381.1144, found 381.1145.

实施例10:5-苯硫基-(1-苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 10: Preparation of 5-phenylthio-(1-benzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h后将反应体系冷却到0℃,加入苯基溴化镁(0.4mmol),恢复室温搅拌12h后,加入饱和氯化铵溶液淬灭反应,使用二氯甲烷萃取3次,合并有机层,无水硫酸钠干燥,旋干后柱层析分离得到白色固体产物54mg,产率79%。1-Phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, and benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD) were added Cl] (0.005 mmol, 1.9 mg), the reaction mixture was stirred at room temperature, and the reaction system was cooled to 0 °C after 12 h, phenylmagnesium bromide (0.4 mmol) was added, and after stirring at room temperature for 12 h, saturated ammonium chloride solution was added The reaction was quenched, extracted three times with dichloromethane, the organic layers were combined, dried over anhydrous sodium sulfate, and spin-dried to obtain 54 mg of a white solid product with a yield of 79%.

Mp=147-148℃.1H NMR(400MHz,CDCl3,TMS):δ8.10(d,J=8.0Hz,2H),7.42-7.36(m,3H),7.28-7.13(m,8H),6.90(d,J=8.0Hz,2H),5.61(s,2H).13C NMR(100MHz,CDCl3):δ150.8,134.5,133.6,130.1,129.5,128.7,128.7,128.6,128.3,128.1,127.0,126.6,126.5,122.4,52.3.Mp=147-148°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 8.10 (d, J=8.0 Hz, 2H), 7.42-7.36 (m, 3H), 7.28-7.13 (m, 8H) , 6.90 (d, J=8.0 Hz, 2H), 5.61 (s, 2H). 13 C NMR (100 MHz, CDCl 3 ): δ 150.8, 134.5, 133.6, 130.1, 129.5, 128.7, 128.7, 128.6, 128.3, 128.1, 127.0, 126.6, 126.5, 122.4, 52.3.

实施例11:5-苯硫基-(1-苄基)-4-对甲氧基苯基-1H-1,2,3-三氮唑的制备Example 11: Preparation of 5-phenylthio-(1-benzyl)-4-p-methoxyphenyl-1H-1,2,3-triazole

在空气下,将1-对甲氧基苯乙炔基硫氰酸酯(0.2mmol,37.8mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h后将反应体系冷却到0℃,加入苯基溴化镁(0.4mmol),恢复室温搅拌12h后,加入饱和氯化铵溶液淬灭反应,使用二氯甲烷萃取3次,合并有机层,无水硫酸钠干燥,旋干后柱层析分离得到黄色固体产物54mg,产率73%。Under air, 1-p-methoxyphenethynyl thiocyanate (0.2 mmol, 37.8 mg) was dissolved in tetrahydrofuran (2 mL), benzyl azide (0.3 mmol, 40.2 mg) and [Cp* Ru(COD)Cl] (0.005 mmol, 1.9 mg), the reaction mixture was stirred at room temperature, and the reaction system was cooled to 0 °C after 12 h, phenylmagnesium bromide (0.4 mmol) was added, and after stirring at room temperature for 12 h, saturated The reaction was quenched with ammonium chloride solution, extracted three times with dichloromethane, and the organic layers were combined, dried over anhydrous sodium sulfate, and spin-dried to obtain 54 mg of a yellow solid product with a yield of 73%.

Mp=94-95℃.1H NMR(400MHz,CDCl3,TMS):δ8.04(d,J=12.0Hz,2H),7.28-7.21(m,5H),7.16-7.12(m,3H),6.94(d,J=8.0Hz,2H),6.89(d,J=8.0Hz,2H),5.59(s,2H),3.83(s,3H).Mp=94-95°C. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 8.04 (d, J=12.0 Hz, 2H), 7.28-7.21 (m, 5H), 7.16-7.12 (m, 3H) ,6.94(d,J=8.0Hz,2H),6.89(d,J=8.0Hz,2H),5.59(s,2H),3.83(s,3H).

实施例12:5-正丁基巯基-(1-苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 12: Preparation of 5-n-butylmercapto-(1-benzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h后将反应体系冷却到0℃,加入正丁基锂(0.4mmol),恢复室温搅拌12h后,加入饱和氯化铵溶液淬灭反应,使用二氯甲烷萃取3次,合并有机层,无水硫酸钠干燥,旋干后柱层析分离得到黄色液体产物42mg,产率65%。1-Phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, and benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD) were added Cl] (0.005 mmol, 1.9 mg), the reaction mixture was stirred at room temperature, and the reaction system was cooled to 0 °C after 12 h, n-butyllithium (0.4 mmol) was added, and after stirring at room temperature for 12 h, saturated ammonium chloride solution was added to quench The reaction was quenched, extracted 3 times with dichloromethane, the organic layers were combined, dried over anhydrous sodium sulfate, spin-dried, and separated by column chromatography to obtain 42 mg of a yellow liquid product with a yield of 65%.

1H NMR(400MHz,CDCl3,TMS):δ8.15(d,J=8.0Hz,2H),7.45-7.41(m,2H),7.36-7.29(m,6H),5.68(s,2H),2.34(t,J=8.0Hz,2H),1.26-1.21(m,2H),1.17-1.11(m,2H),0.68(t,J=8.0Hz,3H). 1 H NMR (400 MHz, CDCl 3 , TMS): δ 8.15 (d, J=8.0 Hz, 2H), 7.45-7.41 (m, 2H), 7.36-7.29 (m, 6H), 5.68 (s, 2H) ,2.34(t,J=8.0Hz,2H),1.26-1.21(m,2H),1.17-1.11(m,2H),0.68(t,J=8.0Hz,3H).

实施例13:5-甲基巯基-(1-苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 13: Preparation of 5-methylmercapto-(1-benzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h后将反应体系冷却到0℃,加入甲基溴化镁(0.4mmol),恢复室温搅拌12h后,加入饱和氯化铵溶液淬灭反应,使用二氯甲烷萃取3次,合并有机层,无水硫酸钠干燥,旋干后柱层析分离得到无色液体产物42mg,产率76%。1-Phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, and benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD) were added Cl] (0.005 mmol, 1.9 mg), the reaction mixture was stirred at room temperature, and the reaction system was cooled to 0 °C after 12 h, methyl magnesium bromide (0.4 mmol) was added, and after stirring at room temperature for 12 h, saturated ammonium chloride solution was added The reaction was quenched, extracted three times with dichloromethane, the organic layers were combined, dried over anhydrous sodium sulfate, and spin-dried to obtain 42 mg of a colorless liquid product with a yield of 76%.

1H NMR(400MHz,CDCl3,TMS):δ8.17-8.14(m,2H),7.46-7.42(m,2H),7.37-7.32(m,6H),5.69(s,2H),1.94(s,3H). 1 H NMR (400MHz, CDCl 3 , TMS): δ 8.17-8.14 (m, 2H), 7.46-7.42 (m, 2H), 7.37-7.32 (m, 6H), 5.69 (s, 2H), 1.94 ( s, 3H).

实施例14:5-异丙基巯基-(1-苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 14: Preparation of 5-isopropylmercapto-(1-benzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h后将反应体系冷却到0℃,加入异丙基溴化镁(0.4mmol),恢复室温搅拌12h后,加入饱和氯化铵溶液淬灭反应,使用二氯甲烷萃取3次,合并有机层,无水硫酸钠干燥,旋干后柱层析分离得到黄色液体产物41mg,产率66%。1-Phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, and benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD) were added Cl] (0.005 mmol, 1.9 mg), the reaction mixture was stirred at room temperature, and the reaction system was cooled to 0 °C after 12 h, and isopropylmagnesium bromide (0.4 mmol) was added. After returning to room temperature and stirring for 12 h, saturated ammonium chloride was added. The solution was quenched and extracted three times with dichloromethane. The organic layers were combined, dried over anhydrous sodium sulfate, and spin-dried to obtain 41 mg of a yellow liquid product with a yield of 66%.

1H NMR(400MHz,CDCl3,TMS):δ8.19(d,J=8.0Hz,2H),7.45-7.41(m,2H),7.37-7.32(m,6H),5.68(s,2H),2.90-2.83(m,1H),1.02(d,J=8.0Hz,6H). 1 H NMR (400 MHz, CDCl 3 , TMS): δ 8.19 (d, J=8.0 Hz, 2H), 7.45-7.41 (m, 2H), 7.37-7.32 (m, 6H), 5.68 (s, 2H) ,2.90-2.83(m,1H),1.02(d,J=8.0Hz,6H).

实施例15:5-环丙基巯基-(1-苄基)-4-苯基-1H-1,2,3-三氮唑的制备Example 15: Preparation of 5-cyclopropylmercapto-(1-benzyl)-4-phenyl-1H-1,2,3-triazole

在空气下,将1-苯乙炔基硫氰酸酯(0.2mmol,32.0mg)溶于四氢呋喃(2mL)中,再加入苄基叠氮(0.3mmol,40.2mg)及[Cp*Ru(COD)Cl](0.005mmol,1.9mg),室温下搅拌反应混合物,反应12h后将反应体系冷却到0℃,加入环丙基溴化镁(0.4mmol),恢复室温搅拌12h后,加入饱和氯化铵溶液淬灭反应,使用二氯甲烷萃取3次,合并有机层,无水硫酸钠干燥,旋干后柱层析分离得到无色液体产物38mg,产率62%。1-Phenylethynyl thiocyanate (0.2 mmol, 32.0 mg) was dissolved in tetrahydrofuran (2 mL) under air, and benzyl azide (0.3 mmol, 40.2 mg) and [Cp*Ru(COD) were added Cl] (0.005mmol, 1.9mg), the reaction mixture was stirred at room temperature, and the reaction system was cooled to 0°C after 12 hours of reaction, cyclopropylmagnesium bromide (0.4mmol) was added, and after stirring at room temperature for 12 hours, saturated ammonium chloride was added The solution was quenched and extracted three times with dichloromethane. The organic layers were combined, dried over anhydrous sodium sulfate, and then spin-dried to obtain 38 mg of a colorless liquid product with a yield of 62%.

1H NMR(400MHz,CDCl3,TMS):δ8.15(d,J=8.0Hz,2H),7.46(t,J=8.0Hz,2H),7.35-7.28(m,6H),5.71(s,2H),1.82-1.76(m,1H),0.60-0.56(m,2H),0.42-0.38(m,2H).13CNMR(100MHz,CDCl3):δ149.1,135.4,130.9,128.8,128.5,128.4,128.3,127.7,127.2,126.6,52.1,16.1,8.4.HRMS(ESI-TOF)m/z calcd for C18H17N3S(M+Na)+330.1035,found330.1037. 1 H NMR (400 MHz, CDCl 3 , TMS): δ 8.15 (d, J=8.0 Hz, 2H), 7.46 (t, J=8.0 Hz, 2H), 7.35-7.28 (m, 6H), 5.71 (s , 2H), 1.82-1.76 (m, 1H), 0.60-0.56 (m, 2H), 0.42-0.38 (m, 2H). 13 CNMR (100MHz, CDCl 3 ): δ149.1, 135.4, 130.9, 128.8, 128.5, 128.4,128.3,127.7,127.2,126.6,52.1,16.1,8.4.HRMS(ESI-TOF)m/z calcd for C 18 H 17 N 3 S(M+Na) + 330.1035,found330.1037.

Claims (7)

1. A preparation method of novel 5-thiocyanate substituted 1,4, 5-trisubstituted 1,2, 3-triazole is characterized by comprising the following steps:
in an organic solvent, under the action of a pentamethylcyclopentadienyl 1, 5-cyclooctadiene ruthenium chloride catalyst, catalyzing a reaction of a thiocyanato internal alkyne compound and an organic azide compound to prepare 5-thiocyanato substituted 1,4, 5-trisubstituted 1,2, 3-triazole, wherein the reaction formula is as follows:
wherein R is1And R2Is alkyl or aryl, R1And R2The same or different;
i is a thiocyanate radical internal alkyne compound;
the mol ratio of the thiocyanato internal alkyne compound to the organic azide compound is 1:1.5-1:3, and the concentration of the thiocyanato internal alkyne compound in the system is 0.01-0.1 mmol/ml;
the dosage of [ Cp, Ru, (COD) Cl ] is 0.5-50 mol% of the thiocyanato internal alkyne compound;
the reaction temperature is between room temperature and 80 ℃, the reaction time is between 12 and 24 hours, and the 5-thiocyanate substituted 1,4, 5-trisubstituted 1,2, 3-triazole with the yield not lower than 66 percent is prepared.
2. The method according to claim 1, wherein the organic solvent is one or more selected from benzene, toluene, diethyl ether, methyl tert-butyl ether, dichloromethane, tetrahydrofuran, trifluorotoluene, cyclohexane, and petroleum ether.
3. A preparation method of novel 5-thio-1, 4, 5-trisubstituted 1,2, 3-triazole is characterized by comprising the following steps:
in an organic solvent, under the action of a pentamethylcyclopentadienyl 1, 5-cyclooctadiene ruthenium chloride catalyst, a 5-thiocyanate substituted 1,4, 5-trisubstituted 1,2, 3-triazole is generated in situ by the reaction of a thiocyanate alkynes compound and an organic azide compound, the 5-thiocyanate substituted 1,4, 5-trisubstituted 1,2, 3-triazole continuously reacts with a lattice reagent or a lithium reagent to generate the novel 5-thio-1, 4, 5-trisubstituted 1,2, 3-triazole, and the reaction formula is as follows:
wherein R is1,R2And R3Is alkyl or aryl, R4Is an alkyl group;
i is a thiocyanate radical internal alkyne compound;
IV is a Grignard reagent;
VI is a lithium reagent;
the mol ratio of the thiocyanato internal alkyne compound to the organic azide compound to the Grignard reagent or the lithium reagent is 1:1.5:2-1:3:4, and the concentration of the thiocyanato internal alkyne compound in the system is 0.01-0.1 mmol/ml;
the dosage of [ Cp, Ru, (COD) Cl ] is 0.5-50 mol% of the thiocyanato internal alkyne compound;
the reaction temperature is 0-room temperature, the reaction time is 24-36 h, and the 5-sulfo-1, 4, 5-trisubstituted 1,2, 3-triazole compound with the yield not less than 62 percent is prepared.
4. The method according to claim 3, wherein the organic solvent is one or more selected from benzene, toluene, diethyl ether, methyl tert-butyl ether, dichloromethane, tetrahydrofuran, trifluorotoluene, cyclohexane, and petroleum ether.
5. The process according to claim 3 or 4, wherein the Grignard reagent is a 1.0mol/L THF solution of phenylmagnesium bromide, a 1.0mol/L THF solution of methylmagnesium bromide, a 1.0mol/L THF solution of isopropylmagnesium bromide or a 1.0mol/L THF solution of cyclopropylmagnesium bromide.
6. The method according to claim 3 or 4, wherein the lithium reagent is a 2.5mol/L n-butyllithium n-hexane solution.
7. The method according to claim 5, wherein the lithium reagent is a 2.5mol/L n-hexane solution of n-butyllithium.
CN201910886781.1A 2019-09-19 2019-09-19 Preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole Withdrawn CN110590685A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910886781.1A CN110590685A (en) 2019-09-19 2019-09-19 Preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910886781.1A CN110590685A (en) 2019-09-19 2019-09-19 Preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole

Publications (1)

Publication Number Publication Date
CN110590685A true CN110590685A (en) 2019-12-20

Family

ID=68861104

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910886781.1A Withdrawn CN110590685A (en) 2019-09-19 2019-09-19 Preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole

Country Status (1)

Country Link
CN (1) CN110590685A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113149916A (en) * 2021-05-07 2021-07-23 江苏中利集团股份有限公司 Preparation method of fluorine-containing 1,4, 5-trisubstituted 1,2, 3-triazole

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101316640A (en) * 2005-09-30 2008-12-03 斯克里普斯研究学院 Ruthenium-Catalyzed Cycloaddition of Alkynes with Organic Azides
CN109305945A (en) * 2018-11-23 2019-02-05 大连理工大学 A kind of preparation method of novel 5-mercapto-1,4,5-trisubstituted 1,2,3-triazole

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101316640A (en) * 2005-09-30 2008-12-03 斯克里普斯研究学院 Ruthenium-Catalyzed Cycloaddition of Alkynes with Organic Azides
CN109305945A (en) * 2018-11-23 2019-02-05 大连理工大学 A kind of preparation method of novel 5-mercapto-1,4,5-trisubstituted 1,2,3-triazole

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BRANT C. BOREN等: ""Ruthenium-Catalyzed Azide-Alkyne Cycloaddition: Scope and Mechanism"", 《J. AM. CHEM. SOC.》 *
PAOLO DESTITO等: ""Ruthenium-Catalyzed Azide–Thioalkyne Cycloadditions in Aqueous Media: A Mild, Orthogonal, and Biocompatible Chemical Ligation"", 《ANGEW. CHEM. INT. ED.》 *
THOMAS CASTANHEIRO等: ""Recent advances in the chemistry of organic thiocyanates"", 《CHEM. SOC. REV.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113149916A (en) * 2021-05-07 2021-07-23 江苏中利集团股份有限公司 Preparation method of fluorine-containing 1,4, 5-trisubstituted 1,2, 3-triazole

Similar Documents

Publication Publication Date Title
WO2016131371A1 (en) Method for preparing formamide compound
CN107721984A (en) A kind of preparation method of trisubstituted 1,2,3 triazole of new 5 amide groups 1,4,5
CN108640880A (en) The synthetic method of 1- alkyl -5- aryl -1,2,3- triazole compounds
CN111468191A (en) A kind of synthetic method of ruthenium carbene catalyst
CN110590685A (en) Preparation method and application of a novel 5-thiocyanate-substituted 1,4,5-trisubstituted 1,2,3-triazole
CN112028819A (en) Organic ligand compound of tetraphenyl ethylene terpyridine, coordination supermolecule, preparation and application thereof
CN110746365B (en) A kind of preparation method of 4-thiocyano-1,4,5-trisubstituted 1,2,3-triazole
CN1114497C (en) Preparation method of self-solidified 'after cyclopentadiene' nickel base olefinic polymerization catalyst
CN109939737B (en) Cobalt carbene catalysts, method for the production thereof, and use thereof for the catalytic hydrogenation of aldehyde and ketone compounds
CN109305945A (en) A kind of preparation method of novel 5-mercapto-1,4,5-trisubstituted 1,2,3-triazole
CN108558944A (en) A kind of preparation method of the novel trisubstituted 1,2,3- triazoles of 4- phosphoryls -1,4,5-
CN109320469A (en) Preparation method of a novel 5-trifluoromethylthio-1,4,5-trisubstituted 1,2,3-triazole
CN112961176B (en) Preparation method of boron-dioxygen ring neutral radical compound
CN112266364B (en) A kind of preparation method of tetrahydroquinoxaline compound
CN114622226A (en) Method for synthesizing alkyl borate through electrocatalysis
CN111471026A (en) Method for preparing 1,3,5-trisubstituted-1,2,4-triazole derivatives in one step
CN111662147A (en) Process for preparing diynes and analogues thereof
CN110698507B (en) Preparation method of aryl vinyl silane compound
CN113024604B (en) Preparation method of C3-alkenylated 2-pyridone derivative
CN116144034B (en) Metallic triangular supramolecules with near-infrared fluorescence, preparation methods and applications
CN115919817B (en) Gediselenium compounds and their synthesis methods and applications
CN115369429B (en) A method for selective hydroboration of alkynes by electrochemical catalysis
CN108947909B (en) A kind of chiral nitrogen heterocyclic carbene precursor compound with imidazolone skeleton and synthesis method thereof
JP7125022B2 (en) Compound
CN112830449B (en) Reversible liquid organic hydrogen storage method based on manganese catalytic hydrogenation and dehydrogenation reaction

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20191220

WW01 Invention patent application withdrawn after publication